WallStreetZenWallStreetZen

NASDAQ: CORT
Corcept Therapeutics Inc Stock Ownership - Who owns Corcept Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Corcept Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Atabak MokariCFO2026-07-1515,833$19.26
$304.94kBuy
James N. WilsonDirector2026-07-151,978$89.49
$177.01kSell
James N. WilsonDirector2026-07-152,974$88.81
$264.12kSell
James N. WilsonDirector2026-07-153,969$87.74
$348.22kSell
James N. WilsonDirector2026-07-151,079$86.78
$93.63kSell
Atabak MokariCFO2026-07-15101$89.43
$9.03kSell
Atabak MokariCFO2026-07-153,520$88.30
$310.82kSell
Atabak MokariCFO2026-07-1528,460$87.89
$2.50MSell
Atabak MokariCFO2026-07-157,919$86.78
$687.18kSell
Atabak MokariCFO2026-07-1524,167$23.06
$557.29kBuy

1 of 18

CORT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CORT insiders and whales buy or sell their stock.

CORT Shareholders

What type of owners hold Corcept Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick G. Enright41.73%44,802,403$4.29BInsider
Blackrock Inc11.32%12,151,276$1.16BInstitution
Bakker Juliet Tammenoms10.33%11,089,541$1.06BInsider
Longitude Venture Partners LP10.21%10,956,002$1.05BInsider
Alta Biopharma Partners II LP9.30%9,982,720$954.85MInsider
G. Leonard Baker Jr.8.79%9,440,067$902.94MInsider
Ingalls Snyder LLC7.09%7,608,716$727.77MInstitution
Tench Coxe6.42%6,890,503$659.08MInsider
Joseph C. Cook Jr.6.30%6,765,805$647.15MInsider
David L. Anderson5.98%6,420,729$614.14MInsider

1 of 3

CORT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CORT29.07%70.93%Net BuyingNet Selling
KRYS79.66%20.34%Net SellingNet Selling
APGE95.76%4.24%Net SellingNet Selling
CYTK90.50%9.50%Net SellingNet Selling
ABVX63.37%0.00%
View Top Biotech Stocks

Corcept Therapeutics Stock Ownership FAQ

Who owns Corcept Therapeutics?

Corcept Therapeutics (NASDAQ: CORT) is owned by 74.12% institutional shareholders, 180.87% Corcept Therapeutics insiders, and 0.00% retail investors. Patrick G. Enright is the largest individual Corcept Therapeutics shareholder, owning 44.80M shares representing 41.73% of the company. Patrick G. Enright's Corcept Therapeutics shares are currently valued at $4.07B.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.